Wardwizard Healthcare Limited

BSE:512063 Stock Report

Market Cap: ₹4.6m

Wardwizard Healthcare Valuation

Is 512063 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 512063 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 512063's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 512063's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 512063?

Key metric: As 512063 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 512063. This is calculated by dividing 512063's market cap by their current revenue.
What is 512063's PS Ratio?
PS Ratio2.1x
Sales₹2.17m
Market Cap₹4.63m

Price to Sales Ratio vs Peers

How does 512063's PS Ratio compare to its peers?

The above table shows the PS ratio for 512063 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.8x
541299 Dr Lalchandani Labs
1.9xn/a₹78.0m
526504 Dolphin Medical Services
5.4xn/a₹41.5m
542918 Gian Life Care
1.6xn/a₹196.4m
544220 Clinitech Laboratory
2.4xn/a₹180.3m
512063 Wardwizard Healthcare
2.1xn/a₹4.6m

Price-To-Sales vs Peers: 512063 is good value based on its Price-To-Sales Ratio (2.1x) compared to the peer average (2.8x).


Price to Sales Ratio vs Industry

How does 512063's PS Ratio compare vs other companies in the IN Healthcare Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
MONOPHARMA Mono Pharmacare
0.4xn/aUS$7.33m
542934 Chandra Bhagat Pharma
0.3xn/aUS$5.95m
530697 Zenlabs Ethica
0.5xn/aUS$3.10m
SAROJA Saroja Pharma Industries India
0.6xn/aUS$2.53m
512063 2.1xIndustry Avg. 3.9xNo. of Companies9PS02.44.87.29.612+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 512063 is good value based on its Price-To-Sales Ratio (2.1x) compared to the Indian Healthcare industry average (4.1x).


Price to Sales Ratio vs Fair Ratio

What is 512063's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

512063 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 512063's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies